Population and Public Health
HIMSS23
Cleveland Clinic’s chief research information officer, Lara Jehi, and Craig Martin, IT product director for population health, discuss how digital tools help clinicians maintain continuity of care for patients with complex health issues.
HIMSS23
Robert Stillman, director of clinical and research informatics at the Ohio State University Wexner Medical Center, discusses the challenges of chairing the Global Health Conference Education Committee for HIMSS23.
HIMSS23
Native Americans' life expectancy is five years lower than the U.S. average. Mitchell Thornbrugh, CIO of the Indian Health Service, talks about the need for a single interoperable medical record to support Native communities’ health equity.
HIMSS23
Stacey Caywood, CEO of Wolters Kluwer Health, discusses how Wolters Kluwer solutions incorporate diversity and inclusivity into the text, images and clinical support sources they provide to help clinicians meet patients’ care needs.
HIMSS23
Dr. Hans Kluge, regional director for Europe at WHO, discusses the need for collaboration between public health workers and technology vendors around the world to improve public trust and health equity.
HIMSS23
Olyvia Phillips, manager of equity initiatives for global healthcare technology incubator MATTER, talks about how Together.health, a consortium of digital health incubators, prioritizes health equity and supports diverse founders.
HIMSS23
Dana Trampas, senior digital health specialist at HIMSS, shares how healthcare organizations can promote and advocate for LGBTQ health equity and inclusion within their patient populations and their workforces.
HIMSS23
Natasha Ramontal, HIMSS digital health strategist for community outcomes and analytics, describes how the Community Care Outcomes Maturity Model (C-COMM) engages and empowers patients by supporting meaningful care relationships.
HIMSS23
Lawrence Whittle, CCO at Verana Health, describes how patient data can be used to improve healthcare, including making clinical trials more efficient and helping clinicians discover which treatments yield the most value.
HIMSS23
Dr. John Showalter, CPO at Linus Health, describes drug therapy advances for Alzheimer's and how technology can help screen and identify at-risk patients sooner to optimize outcomes and quality of life.